• Depot
  • Watchlist
  • Glocke
  • Handeln

    • Novartis AG ADR News

    91,80 € 0,00% +0,00 €
    09:24:27 Uhr L&S RT aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 907122
    ISIN: US66987V1098
    US-Symbol: NVS
    Typ: Aktie

    Novartis AG ADR News

    15.04.24 - PR Newswire
    New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
    New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy ...
    06.04.24 - PR Newswire
    New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
    New Novartis data show early addition of twice-​yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-​world ...
    10.12.23 - PR Newswire
    Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
    Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal ...
    06.12.23 - PR Newswire
    Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH
    Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with ...
    16.09.23 - Small- & Micro Cap Investment
    Eine Industrie im Rausch: Green Rush an der Börse – Tilray, Water Ways und SynBiotic sind dabei
    Eine komplette Industrie ist im Rausch. Vor rund 80 Jahren war Cannabis fast überall auf der Welt verboten. Nun öffnen sich nach und nach die Türen, welche auf einen Markt ...
    11.09.23 - PR Newswire
    Novartis Issues Voluntary Nationwide Recall of One Lot of Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL due to Crystallization
    Novartis Issues Voluntary Nationwide Recall of One Lot of Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL due to Crystallization PR Newswire
    10.09.23 - Julius Weiß
    Wochenausblick – Trotz hartnäckiger Inflation sind Anleger positiv gestimmt
    Zum Start in die neue Börsenwoche informieren wir jeden Sonntag über Wirt­schafts­daten, Quartals­zahlen und mehr. Neben den Arbeits­markt­daten aus UK und  dem EZB-...
    30.08.23 - PR Newswire
    Thinking about trading options or stock in NVIDIA, SoundHound AI, Novartis, Faraday Future Intelligent Electric, or Medical Properties Trust?
    Thinking about trading options or stock in NVIDIA, SoundHound AI, Novartis, Faraday Future Intelligent Electric, or Medical Properties Trust? PR Newswire
    08.06.23 - PR Newswire
    KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA
    KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-​MUTANT GRADE 2 & 3 GLIOMA PR Newswire
    20.05.23 - Small- & Micro Cap Investment
    Water Ways: Aktien des Green Rush: Cannabis-Markt auf dem Vormarsch – Tilray, Water Ways und SynBiotic halten Schritt
    Eine komplette Industrie ist im Rausch. Vor rund 80 Jahren war Cannabis fast überall auf der Welt verboten. Nun öffnen sich nach und nach die Türen, welche auf einen Markt ...
    25.04.23 - PR Newswire
    Thinking about trading options or stock in Spotify Technology, Novartis, Apple, UnitedHealth Group, or Honeywell?
    Thinking about trading options or stock in Spotify Technology, Novartis, Apple, UnitedHealth Group, or Honeywell? PR Newswire
    18.04.23 - Small- & Micro Cap Investment
    Water Ways: Aktien des Green Rush: Cannabis-Markt auf dem Vormarsch – Tilray, Water Ways und SynBiotic halten Schritt
    Eine komplette Industrie ist im Rausch. Vor rund 80 Jahren war Cannabis fast überall auf der Welt verboten. Nun öffnen sich nach und nach die Türen, welche auf einen Markt ...
    05.03.23 - Small- & Micro Cap Investment
    Water Ways: Aktien des Green Rush: Cannabis-Markt auf dem Vormarsch – Tilray, Water Ways und SynBiotic halten Schritt
    Eine komplette Industrie ist im Rausch. Vor rund 80 Jahren war Cannabis fast überall auf der Welt verboten. Nun öffnen sich nach und nach die Türen, welche auf einen Markt ...
    21.11.22 - PR Newswire
    Thinking about trading options or stock in AstraZeneca, Jacobs Solutions, J M Smucker, Tesla, or Novartis?
    Thinking about trading options or stock in AstraZeneca, Jacobs Solutions, J M Smucker, Tesla, or Novartis? PR Newswire
    09.11.22 - PR Newswire
    Thinking about trading options or stock in Trade Desk, Meta, Novartis, Twitter, or Costco?
    Thinking about trading options or stock in Trade Desk, Meta, Novartis, Twitter, or Costco? PR Newswire
    13.07.22 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Novartis AG - NVS
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Novartis AG - NVS PR Newswire
    08.06.22 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Novartis AG - NVS
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Novartis AG - NVS PR Newswire
    10.01.22 - PR Newswire
    New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024
    New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024 FN Media Group Presents USA News Group News Commentary PR Newswire
    10.01.22 - PR Newswire
    New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024
    New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024 FN Media Group Presents USA News Group News Commentary PR Newswire
    19.09.21 - PR Newswire
    Novartis presents new Kisqali® data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer
    Novartis presents new Kisqali® data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer - With the MONALEESA-2 final analysis, only ...

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »